全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Characteristics of Non-Obstructive Coronary Syndromes (Minoca, Inoca, Anoca): A Cross-Sectional Study in a First Interventional Cardiology Center in Central Africa

DOI: 10.4236/ojmi.2026.162010, PP. 71-82

Keywords: Non-Obstructive Coronary Syndrome, MINOCA, INOCA, ANOCA, Coronary Angiography, Cameroon

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Non-Obstructive Coronary Syndromes (NOCS), including MINOCA, INOCA, and ANOCA, represent a growing proportion of coronary syndromes still poorly documented in Sub-Saharan Africa. Objective: To describe the epidemiological, clinical, angiographic, and therapeutic characteristics of NOCS and compare them with Obstructive Coronary Syndromes (OCS) in patients managed in Yaoundé. Methods: This was a descriptive and analytical cross-sectional study conducted over a three-year period (November 2022-November 2025) at the Yaoundé General Hospital. All consecutive patients admitted for coronary syndrome who underwent coronary angiography were included. Patients were classified as NOCS or OCS based on the presence or absence of coronary lesions ≥ 50% via Quantitative Coronary Angiography (QCA). Statistical analysis was performed using SPSS 26.0. Results: Out of 111 patients presenting with coronary syndrome, 25 (22.5%) had NOCS. Patients with NOCS were significantly younger than those with OCS. Unstable angina was more frequent in the NOCS group. Dual Antiplatelet Therapy (DAPT) was less frequently utilized in these patients. Conclusion: NOCS constitutes a frequent and clinically relevant entity in Yaoundé. Their recognition necessitates an individualized diagnostic and therapeutic approach, even in the absence of significant coronary stenosis.

References

[1]  Boden, W.E., De Caterina, R., Kaski, J.C., Bairey Merz, N., Berry, C., Marzilli, M., et al. (2024) Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines. Circulation, 150, 1631-1637.
https://doi.org/10.1161/circulationaha.123.065656
[2]  Parlati, A.L.M., Nardi, E., Sucato, V., Madaudo, C., Leo, G., Rajah, T., et al. (2025) ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes. Journal of Cardiovascular Development and Disease, 12, Article 64.
https://doi.org/10.3390/jcdd12020064
[3]  Lindahl, B., Baron, T., Albertucci, M. and Prati, F. (2021) Myocardial Infarction with Non-Obstructive Coronary Artery Disease. EuroIntervention, 17, e875-e887.
https://doi.org/10.4244/eij-d-21-00426
[4]  Kunadian, V., Chieffo, A., Camici, P.G., Berry, C., Escaned, J., Maas, A.H.E.M., et al. (2021) An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention, 16, 1049-1069.
https://doi.org/10.4244/eijy20m07_01
[5]  Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., et al. (2020) 2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes. European Heart Journal, 41, 407-477.
[6]  Tamis-Holland, J.E., Jneid, H., Reynolds, H.R., Agewall, S., Brilakis, E.S., Brown, T.M., et al. (2019) Contemporary Diagnosis and Management of Patients with Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement from the American Heart Association. Circulation, 139, e891-e908.
https://doi.org/10.1161/cir.0000000000000670
[7]  Khattab, E., Karelas, D., Pallas, T., Kostakis, P., Papadopoulos, C.H., Sideris, S., et al. (2024) MINOCA: A Pathophysiological Approach of Diagnosis and Treatment—A Narrative Review. Biomedicines, 12, Article 2457.
https://doi.org/10.3390/biomedicines12112457
[8]  Boivin-Proulx, L., Haddad, K., Lombardi, M., Chong, A.Y., Escaned, J., Mukherjee, S., et al. (2024) Pathophysiology of Myocardial Infarction with Nonobstructive Coronary Artery Disease: A Contemporary Systematic Review. CJC Open, 6, 380-390.
https://doi.org/10.1016/j.cjco.2023.11.014
[9]  Parwani, P., Kang, N., Safaeipour, M., Mamas, M.A., Wei, J., Gulati, M., et al. (2023) Contemporary Diagnosis and Management of Patients with MINOCA. Current Cardiology Reports, 25, 561-570.
https://doi.org/10.1007/s11886-023-01874-x
[10]  Neumann, F., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A.P., Benedetto, U., et al. (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40, 87-165.
https://doi.org/10.1093/eurheartj/ehy394
[11]  Stone, G.W., Sabik, J.F., Serruys, P.W., Simonton, C.A., Généreux, P., Puskas, J., et al. (2016) Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. New England Journal of Medicine, 375, 2223-2235.
https://doi.org/10.1056/nejmoa1610227
[12]  Lawton, J.S., Tamis-Holland, J.E., Bangalore, S., Bates, E.R., Beckie, T.M., Bischoff, J.M., et al. (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e4-e17.
https://doi.org/10.1161/cir.0000000000001039
[13]  Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G., Mack, M., et al. (2012) Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine, 367, 2375-2384.
https://doi.org/10.1056/nejmoa1211585

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133